ProfileGDS4718 / 219410_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 41% 50% 89% 38% 49% 30% 54% 49% 54% 45% 45% 47% 68% 59% 87% 83% 63% 56% 71% 85% 41% 58% 57% 57% 46% 54% 56% 74% 53% 32% 51% 68% 62% 41% 80% 67% 32% 62% 33% 88% 62% 44% 87% 57% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.0258241
GSM549102patient 115, normal, homogenized [OPG study]5.5215850
GSM549104patient 119, normal, homogenized [OPG study]9.1300889
GSM549108patient 138, normal, homogenized [OPG study]4.9304438
GSM549119patient 077, normal, homogenized [OPG study]5.4685949
GSM549133patient 032, cancer, homogenized [OPG study]4.5001830
GSM549139patient 042, cancer, homogenized [OPG study]5.7037854
GSM549099patient 107, normal, homogenized [OPG study]5.4655849
GSM549109patient 139, normal, homogenized [OPG study]5.7380954
GSM549110patient 046, normal, homogenized [OPG study]5.2264445
GSM549114patient 063, normal, homogenized [OPG study]5.2181245
GSM549122patient 082, normal, homogenized [OPG study]5.3705747
GSM549134patient 033, cancer, homogenized [OPG study]6.7023268
GSM549136patient 036, cancer, homogenized [OPG study]6.0141459
GSM549140patient 044, cancer, homogenized [OPG study]8.7465187
GSM549111patient 047, normal, homogenized [OPG study]8.2692483
GSM549113patient 057, normal, homogenized [OPG study]6.3036363
GSM549132patient 031, cancer, homogenized [OPG study]5.8291656
GSM549137patient 038, cancer, homogenized [OPG study]6.9770871
GSM549142patient 047, cancer, homogenized [OPG study]8.0839285
GSM549100patient 110, normal, homogenized [OPG study]5.0678341
GSM549107patient 135, normal, homogenized [OPG study]5.9668158
GSM549115patient 068, normal, homogenized [OPG study]5.8646557
GSM549116patient 072, normal, homogenized [OPG study]5.9577157
GSM549120patient 078, normal, homogenized [OPG study]5.3026446
GSM549131patient 030, cancer, homogenized [OPG study]5.6961154
GSM549118patient 074, normal, homogenized [OPG study]5.8731256
GSM549129patient 027, cancer, homogenized [OPG study]7.3389774
GSM549123patient 088, normal, homogenized [OPG study]5.6552953
GSM549124patient 006, cancer, homogenized [OPG study]4.6824232
GSM549126patient 015, cancer, homogenized [OPG study]5.5288351
GSM549128patient 025, cancer, homogenized [OPG study]6.8017368
GSM549103patient 117, normal, homogenized [OPG study]6.2695362
GSM549117patient 073, normal, homogenized [OPG study]5.0238941
GSM549138patient 041, cancer, homogenized [OPG study]7.8760180
GSM549141patient 045, cancer, homogenized [OPG study]6.6573367
GSM549130patient 028, cancer, homogenized [OPG study]4.6658832
GSM549101patient 111, normal, homogenized [OPG study]6.2988962
GSM549105patient 128, normal, homogenized [OPG study]4.7139533
GSM549106patient 134, normal, homogenized [OPG study]9.1090688
GSM549112patient 048, normal, homogenized [OPG study]6.2594262
GSM549125patient 011, cancer, homogenized [OPG study]5.2090844
GSM549127patient 024, cancer, homogenized [OPG study]8.6355987
GSM549135patient 035, cancer, homogenized [OPG study]5.9198957